Prestige Consumer Healthcare Cash Flow Statement
NYSE: PBHHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Prestige Consumer Healthcare free cash flow
In fiscal 2026, Prestige Consumer Healthcare generated $257.6 million of operating cash flow and spent $11.2 million on capital expenditures. That left free cash flow of $246.4 million, a free-cash-flow margin of 22.6% of revenue. Free cash flow was up 1.3% from the prior year's $243.3 million.
Prestige Consumer Healthcare returned $156.3 million to shareholders through share repurchases, equal to 63% of free cash flow.
Summary generated from market data by MetaCap's automated system. Methodology
Prestige Consumer Healthcare cash flow statement (annual)
| Fiscal year (USD) | FY 20262026-03-31 | FY 20252025-03-31 | FY 20242024-03-31 | FY 20232023-03-31 | FY 20222022-03-31 | FY 20212021-03-31 | FY 20202020-03-31 | FY 20192019-03-31 | FY 20182018-03-31 | FY 20172017-03-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | 190.30M | 214.60M | 209.34M | -82.31M | 205.38M | 164.68M | 142.28M | -35.80M | 339.57M | 69.39M |
| Net Income growth (YoY) | -11.32% | +2.52% | — | -140.07% | +24.71% | +15.74% | — | -110.54% | +389.33% | -30.54% |
| Depreciation & Amortization | 31.27M | 30.17M | 30.68M | 32.63M | 32.09M | 30.16M | 29.00M | 31.78M | 33.43M | 25.79M |
| Stock-Based Compensation | 10.84M | 11.16M | 14.01M | 12.40M | 9.04M | 8.54M | 7.64M | 7.44M | 8.91M | 8.15M |
| Change in Working Capital | -9.87M | -33.41M | -31.29M | -46.89M | -3.77M | 4.36M | 19.07M | -6.89M | -15.33M | -7.34M |
| Operating Cash Flow | 257.63M | 251.51M | 248.93M | 229.72M | 259.92M | 235.61M | 217.12M | 189.28M | 210.11M | 148.67M |
| Capital Expenditures | -11.18M | -8.22M | -9.55M | -7.78M | -9.64M | -22.24M | -14.56M | -10.48M | -12.53M | -2.98M |
| Investing Cash Flow | -136.84M | -17.45M | -20.11M | -11.58M | -256.51M | -22.24M | -16.57M | 55.43M | -11.56M | -694.60M |
| Share Repurchases | -156.28M | -51.51M | -25.00M | -50.00M | 0 | -11.87M | -56.72M | -49.98M | 0 | 0 |
| Debt Issued | — | — | — | 0 | 0 | 600.00M | 400.00M | 0 | 250.00M | 0 |
| Debt Repaid | — | — | — | 0 | 0 | -600.00M | -400.00M | 0 | 0 | 0 |
| Financing Cash Flow | -156.06M | -182.07M | -241.01M | -185.85M | -7.57M | -279.42M | -131.43M | -249.33M | -208.96M | 560.96M |
| Net Change in Cash | -34.02M | 51.41M | -12.02M | 31.30M | -5.12M | -62.46M | 67.23M | -5.02M | -9.31M | 14.63M |
| Free Cash Flow | 246.45M | 243.29M | 239.38M | 221.93M | 250.28M | 213.36M | 202.56M | 178.80M | 197.58M | 145.69M |
This table shows 10 annual periods of Prestige Consumer Healthcare's cash flow statement, from FY 2026 back to FY 2017, across 14 line items including net income, depreciation & amortization, stock-based compensation. Values in USD; B = billions, M = millions. Fiscal periods follow PBH's reporting calendar. What is a cash flow statement?